{"id":56726,"date":"2026-05-23T13:52:26","date_gmt":"2026-05-23T13:52:26","guid":{"rendered":"https:\/\/www.bridge-global.com\/blog\/?p=56726"},"modified":"2026-05-26T05:21:44","modified_gmt":"2026-05-26T05:21:44","slug":"medical-saas-product-engineering-support","status":"publish","type":"post","link":"https:\/\/www.bridge-global.com\/blog\/medical-saas-product-engineering-support\/","title":{"rendered":"Mastering Medical SaaS Product Engineering Support"},"content":{"rendered":"<p>Your product probably works in demo conditions. The trouble starts after procurement, security review, pilot rollout, and the first serious integration with a hospital system.<\/p>\n<p>That&#8217;s the point where many teams discover they don&#8217;t have a product problem. They have an operating model problem. Release slows down because every change needs traceability. Integrations look fine at the API layer but fail in real workflows. AI features impress in testing and then create ambiguity once clinicians start relying on them.<\/p>\n<p>This is why medical SaaS product engineering support matters. It isn&#8217;t just extra development capacity. It&#8217;s the discipline that keeps a healthcare product secure, auditable, interoperable, and maintainable after launch, when significant risk shows up.<\/p>\n<h2>Why Standard Engineering Support Fails in HealthTech<\/h2>\n<p>A familiar pattern shows up in healthtech startups and growth-stage teams. They ship a solid MVP, win early interest, and then hit resistance from the market they need to serve. Security questionnaires get stuck. Implementation timelines stretch. A customer asks for EHR integration, audit evidence, role-based access hardening, and change control documentation. Suddenly, the backlog is no longer about features.<\/p>\n<p>Standard product teams usually respond by patching the visible issue. They add another API endpoint, another manual QA pass, and another spreadsheet for compliance evidence. That can keep the product moving for a while. It doesn&#8217;t create a system that survives repeated audits, complex integrations, or higher clinical usage.<\/p>\n<p>Healthcare is forcing this shift at the market level, too. The global healthcare SaaS market was valued at about $25.13 billion in 2024 and is projected to reach roughly $74.74 billion by 2030, according to this <a href=\"https:\/\/htdhealth.com\/insights\/healthcare-saas-market-overview-and-implementation-strategies\/\" target=\"_blank\" rel=\"noopener\">healthcare SaaS market overview<\/a>. Growth at that scale changes what support has to look like. You&#8217;re not maintaining a web app. You&#8217;re supporting software that sits inside clinical, administrative, and regulatory workflows.<\/p>\n<blockquote>\n<p>Standard engineering support optimizes for delivery speed. Medical SaaS support has to optimize for delivery speed, auditability, and failure containment at the same time.<\/p>\n<\/blockquote>\n<p>The harsh part is that the product can appear healthy right up to the moment it enters a serious buyer&#8217;s environment. A release pipeline without compliance traceability won&#8217;t hold up. A security model built for generic SaaS won&#8217;t satisfy healthcare scrutiny. An integration team without governance discipline will keep \u201cfixing\u201d interfaces that were never semantically aligned in the first place.<\/p>\n<h3>Where the cracks usually appear<\/h3>\n<ul>\n<li>\n<p><strong>Implementation friction:<\/strong> Teams underestimate onboarding into provider environments, especially when legacy systems, consent rules, and workflow-specific requirements show up.<\/p>\n<\/li>\n<li>\n<p><strong>Compliance drift:<\/strong> Design intent, test evidence, and production changes stop lining up, which creates audit exposure.<\/p>\n<\/li>\n<li>\n<p><strong>Operational blind spots:<\/strong> Incidents get handled ad hoc because monitoring, escalation paths, and ownership weren&#8217;t designed early.<\/p>\n<\/li>\n<\/ul>\n<p>A specialized <a href=\"https:\/\/www.bridge-global.com\/whitepapers\/ai-regulatory-compliance-security-medtech\">AI regulatory compliance and security guide for MedTech<\/a> is useful at this stage because it forces the right questions before the platform is under pressure.<\/p>\n<p>What fails in HealthTech isn&#8217;t usually coding ability. It&#8217;s the assumption that healthcare is just another SaaS vertical.<\/p>\n<h2>The Five Pillars of Medical SaaS Engineering Support<\/h2>\n<p>A serious support model has to cover the full product lifecycle, not just bug fixing and uptime. In practice, the work clusters into five pillars.<\/p>\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/05\/medical-saas-product-engineering-support-engineering-support.jpg\" alt=\"Mastering Medical SaaS Product Engineering Support\" width=\"1152\" height=\"640\" \/><\/figure>\n<h3>Compliance and security by design<\/h3>\n<p>This pillar starts before the first release. Teams need controls for access, auditability, documentation, and change management built into delivery workflows. In healthcare, compliance can&#8217;t sit in a separate lane and \u201creview\u201d the product after development is done.<\/p>\n<p>The practical question is simple. Can your team explain why a design decision was made, what risk it addressed, how it was tested, and what changed afterward? If the answer depends on tribal knowledge, support is too weak.<\/p>\n<h3>Scalability and performance<\/h3>\n<p>Medical SaaS systems don&#8217;t just scale by adding infrastructure. They scale by preserving predictable behavior under operational stress. That includes background jobs, clinician-facing workflows, third-party dependencies, and tenant isolation.<\/p>\n<p>A scalable architecture should let you update one service without putting the whole platform at risk. In this context, modular services, staged rollout patterns, and performance testing earn their keep.<\/p>\n<h3>Interoperability and integration<\/h3>\n<p>Many products lose months grappling with buyer integration demands. Healthcare buyers don&#8217;t just want APIs. They need dependable exchange with EHRs, payer systems, labs, imaging platforms, and device feeds.<\/p>\n<p>With the European Health Data Space formally adopted in 2024, cross-border data access and interoperability requirements are expanding, which makes audit-ready integration engineering more important for medical SaaS support, as discussed in this <a href=\"https:\/\/www.promedsci.org\/articles\/Bridging%20the%20Gap%20Between%20Healthcare%20Software%20Products%20and%20Sector-Based%20Requirements\" target=\"_blank\" rel=\"noopener\">analysis of healthcare software product requirements<\/a>.<\/p>\n<h3>Data and AI management<\/h3>\n<p>Medical products now need support for ingestion pipelines, data quality controls, model integration, and production oversight. That applies whether AI is doing classification, summarization, prediction, or workflow prioritization.<\/p>\n<p>If your team offers <a href=\"https:\/\/www.bridge-global.com\/healthcare\">custom healthcare software development<\/a> or broader <a href=\"https:\/\/www.bridge-global.com\/services\/saas-solutions\">SaaS product development<\/a>, this is usually the pillar that exposes whether the engineering model is mature or still feature-first.<\/p>\n<h3>Reliability and uptime<\/h3>\n<p>Reliability in healthcare means more than keeping servers online. It means safe degradation, recoverability, observability, and fast incident handling when something breaks in a live care workflow.<\/p>\n<blockquote>\n<p><strong>Practical rule:<\/strong> If support can&#8217;t tell you which failures are acceptable, which require rollback, and which require human escalation, the platform isn&#8217;t ready for regulated use.<\/p>\n<\/blockquote>\n<p>The five pillars work together. Weakness in one usually shows up as pain in another.<\/p>\n<h2>Structuring Your Team and Choosing an Engagement Model<\/h2>\n<p>A medical SaaS platform needs more than developers, a QA lead, and a DevOps engineer. The minimum viable support structure usually includes people who can own regulatory traceability, security architecture, test automation, integration design, and data operations. Without that spread of skills, teams keep borrowing expertise late, which is expensive and slows decisions.<\/p>\n<h3>The roles that actually matter<\/h3>\n<p>A workable setup often includes:<\/p>\n<ul>\n<li>\n<p><strong>Product engineering lead:<\/strong> Owns architecture, release discipline, and technical trade-offs against business goals.<\/p>\n<\/li>\n<li>\n<p><strong>Security and compliance specialists:<\/strong> Translate requirements into controls, evidence, and review gates.<\/p>\n<\/li>\n<li>\n<p><strong>QA and validation engineers:<\/strong> Focus on regression depth, workflow testing, and release confidence.<\/p>\n<\/li>\n<li>\n<p><strong>Integration engineers:<\/strong> Handle HL7, FHIR, mapping logic, payload validation, and partner system behavior.<\/p>\n<\/li>\n<li>\n<p><strong>Data and AI engineers:<\/strong> Maintain pipelines, model deployment patterns, and production monitoring where AI is involved.<\/p>\n<\/li>\n<\/ul>\n<p>Effective support covers the full lifecycle from design to maintenance with compliance traceability embedded throughout. Teams are also using automated pipelines and ML-assisted testing to detect defects and compliance risks before release, as outlined in this <a href=\"https:\/\/intellias.com\/healthcare-product-engineering\/\" target=\"_blank\" rel=\"noopener\">healthcare product engineering overview<\/a>.<\/p>\n<h3>Comparing engagement models<\/h3>\n<p>The delivery model affects speed, accountability, and access to scarce expertise. Consequently, many CTOs make a clean financial decision that becomes an operational problem six months later.<\/p>\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><th>Model<\/th><th>Cost<\/th><th>Access to Expertise<\/th><th>Scalability<\/th><th>Best For<\/th><\/tr><tr><td>In-house team<\/td><td>Higher fixed commitment<\/td><td>Strong if you can hire well<\/td><td>Slower to expand<\/td><td>Core platforms with stable funding and long-term roadmap ownership<\/td><\/tr><tr><td>Staff augmentation<\/td><td>Flexible but can fragment ownership<\/td><td>Good for targeted gaps<\/td><td>Moderate<\/td><td>Teams that already have strong internal architecture and governance<\/td><\/tr><tr><td>Project-based vendor<\/td><td>Defined scope, tighter short-term control<\/td><td>Varies by vendor<\/td><td>Limited after handoff<\/td><td>Discrete modernization or integration projects<\/td><\/tr><tr><td>Dedicated partner team<\/td><td>Ongoing operating cost with broader coverage<\/td><td>Strong across disciplines if structured well<\/td><td>High<\/td><td>Products needing continuous support across engineering, compliance, and operations<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n<p>If you&#8217;re weighing augmentation against managed delivery, this <a href=\"https:\/\/www.thirstysprout.com\/post\/managed-services-vs-staff-augmentation\" target=\"_blank\" rel=\"noopener\">guide to AI talent solutions<\/a> is useful because it explains where each model breaks down once specialization becomes necessary.<\/p>\n<h3>What usually works in practice<\/h3>\n<p>Early-stage teams often do well with a hybrid approach. Keep product ownership and clinical context in-house. Add a partner for regulated delivery operations, integration support, and hard-to-hire specialist roles. That&#8217;s often more realistic than trying to build every capability internally at once.<\/p>\n<p>For teams comparing <a href=\"https:\/\/www.bridge-global.com\/service-models\">software development service models<\/a> or evaluating a structured <a href=\"https:\/\/www.bridge-global.com\/service-models\/full-cycle-delivery-model-guide\">full-cycle delivery model guide<\/a>, the key question is not \u201cwhich model is cheapest?\u201d It&#8217;s \u201cwhich model lets us maintain release quality and audit readiness without slowing the roadmap to a crawl?\u201d<\/p>\n<p>A weak model creates coordination overhead. A strong one creates decision velocity.<\/p>\n<h2>Integrating AI Safely from Development to Deployment<\/h2>\n<p>A medical SaaS team ships an AI-assisted workflow on schedule. Two weeks later, support tickets start to climb. Clinicians are not reporting outages. They are reporting inconsistent suggestions, missing context, and recommendations they no longer trust. That is the pattern that catches teams off guard. In healthcare, AI usually fails as an operational control problem before it fails as a software delivery problem.<\/p>\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/05\/medical-saas-product-engineering-support-ai-integration.jpg\" alt=\"A five-step diagram showing the process of safely integrating AI into medical SaaS product development.\" \/><\/figure>\n<p>Model integration adds work across the whole product stack. You need data controls, validation rules tied to clinical use, production monitoring, incident handling, and a documented process for model updates. Teams that treat AI as a feature owned only by data science usually create gaps in accountability. Those gaps turn into compliance exposure, patient safety risk, and long release freezes while everyone argues about ownership.<\/p>\n<h3>The support stack around the model<\/h3>\n<p>Safe AI support starts with traceability. Teams need controlled ingestion, de-identification where appropriate, versioned datasets, prompt and model version records, and a clear account of what training or retrieval data influenced behavior. If lineage is weak, validation gets weak. If validation gets weak, change approval becomes guesswork.<\/p>\n<p>Validation also has to reflect the actual workflow. Technical accuracy is only one check. A model can perform well in a test harness and still create clinical risk by surfacing low-value alerts, hiding uncertainty, or interrupting review steps at the wrong time.<\/p>\n<p>The hard question is simple: what happens when the model is wrong?<\/p>\n<p>A capable support function answers that before release. It defines fallback behavior, escalation paths, override handling, and the evidence needed to decide whether an issue is a prompt problem, a data problem, a model problem, or a workflow design problem.<\/p>\n<h3>Deployment is where governance becomes concrete<\/h3>\n<p>Once AI is live, operating discipline matters more than launch quality. Teams need clear ownership for monitoring, thresholds for intervention, and a release process that treats model changes with the same seriousness as application changes.<\/p>\n<p>That means answering practical questions such as:<\/p>\n<ul>\n<li>\n<p><strong>Who owns production behavior:<\/strong> Product, platform engineering, data science, security, or clinical operations?<\/p>\n<\/li>\n<li>\n<p><strong>What triggers action:<\/strong> Drift, complaint trends, override rates, unexplained output changes, or audit findings?<\/p>\n<\/li>\n<li>\n<p><strong>How are updates released:<\/strong> Fixed release windows, canary rollout, manual approval gates, or emergency rollback?<\/p>\n<\/li>\n<li>\n<p><strong>What is shown to the user:<\/strong> Confidence signals, supporting context, human review prompts, or a clear fallback when AI should stay out of the way?<\/p>\n<\/li>\n<\/ul>\n<p>Teams evaluating <a href=\"https:\/\/www.bridge-global.com\/services\/artificial-intelligence-development\">AI development services for healthcare software delivery<\/a> should look past model build capability and examine how the provider handles monitoring, governance, and post-release verification. That is the operating system around the feature, and it determines whether AI remains usable under regulatory scrutiny.<\/p>\n<p>Product leaders still defining where AI belongs in the workflow may also find this perspective on <a href=\"https:\/\/figr.design\/blog\/ai-in-product-management\" target=\"_blank\" rel=\"noopener\">AI for product managers<\/a> useful. It focuses on product ownership and decision-making, which is where many healthcare AI projects start to drift.<\/p>\n<h3>What good AI support looks like<\/h3>\n<p>Good support includes clinician review at the right checkpoints, production observability for both system and model behavior, rollback paths, incident review with root-cause analysis, and explicit approval rules for model or prompt changes. It also includes continuous verification. Teams need to keep checking whether the model still performs safely as data patterns, user behavior, and downstream workflows change.<\/p>\n<p>If your AI plan ends at deployment, you have a release milestone, not an operating model.<\/p>\n<h2>A Practical Checklist for Vetting Your Technology Partner<\/h2>\n<p>Most RFPs are too generic for healthcare. They ask about team size, cloud experience, tech stack, and delivery methodology. Those questions matter, but they won&#8217;t tell you whether a partner can handle the operational burden of a medical SaaS platform.<\/p>\n<p>You need questions that force specifics. Vague confidence is easy to fake. Concrete process is not.<\/p>\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/05\/medical-saas-product-engineering-support-vetting-checklist.jpg\" alt=\"A practical checklist for evaluating technology partners for medical SaaS product engineering and development projects.\" \/><\/figure>\n<h3>Questions that expose real capability<\/h3>\n<p>Ask the partner to walk through their actual delivery mechanics:<\/p>\n<ul>\n<li>\n<p><strong>Compliance evidence:<\/strong> How do you generate, review, and preserve design decisions, risk records, test artifacts, and release evidence across the lifecycle?<\/p>\n<\/li>\n<li>\n<p><strong>Security operations:<\/strong> How do you handle access reviews, incident response, vulnerability remediation, and environment separation for sensitive health data?<\/p>\n<\/li>\n<li>\n<p><strong>Integration depth:<\/strong> Show us examples of difficult <a href=\"https:\/\/www.bridge-global.com\/healthcare\/tools-and-integrations\">healthcare integrations<\/a>, especially where data mapping, terminology mismatch, or legacy workflows complicated delivery.<\/p>\n<\/li>\n<li>\n<p><strong>Testing discipline:<\/strong> What&#8217;s automated, what still requires manual validation, and how do you test real clinical scenarios before rollout?<\/p>\n<\/li>\n<li>\n<p><strong>Post-launch ownership:<\/strong> Who handles monitoring, defect triage, rollback coordination, and release approval after go-live?<\/p>\n<\/li>\n<\/ul>\n<p>A partner that only talks about APIs and connectors is a risk. True interoperability in healthcare requires more than API connectivity. It needs standardized data models and consistent governance. Engineering teams have to maintain the data contract through canonical mapping and schema management for HL7 and FHIR, because semantic mismatch is often the primary point of failure, as explained in this <a href=\"https:\/\/testdouble.com\/insights\/healthcare-software-teams-keep-fixing-symptoms-real-problems-run-deeper\" target=\"_blank\" rel=\"noopener\">healthcare interoperability analysis<\/a>.<\/p>\n<h3>What strong answers sound like<\/h3>\n<p>Good partners talk about artifacts, ownership, and failure modes. They can explain how they handle schema versioning, payload validation, release gates, traceability, and workflow rollback. They don&#8217;t hide behind \u201cbest practices.\u201d<\/p>\n<blockquote>\n<p><strong>Ask for process, not promises.<\/strong> A capable team can describe who signs off, what gets logged, how evidence is stored, and what happens when a production change introduces risk.<\/p>\n<\/blockquote>\n<p>You should also ask for proof that they&#8217;ve worked through similar conditions. Reviewing <a href=\"https:\/\/www.bridge-global.com\/client-cases\">client cases<\/a> helps, but don&#8217;t stop at logos. Ask what broke, how they diagnosed it, and what controls they added afterward.<\/p>\n<p>A weak partner sells development. A strong one can explain operations.<\/p>\n<h2>Your Roadmap for Onboarding a Support Partner<\/h2>\n<p>The onboarding phase determines whether the partnership becomes an asset or overhead. If you rush straight into sprint execution, the outside team will spend weeks rediscovering architecture, constraints, and undocumented risks. That&#8217;s how support engagements start busy and end misaligned.<\/p>\n<p>A better approach is phased and operational from the start.<\/p>\n<h3>Phase one through phase three<\/h3>\n<ol>\n<li>\n<p><strong>Discovery and technical audit<\/strong><br \/>Review the architecture, deployment model, code hotspots, integration map, security posture, test coverage, and documentation quality. The point is to surface where the product is fragile before new work starts.<\/p>\n<\/li>\n<li>\n<p><strong>Operational goal setting<\/strong><br \/>Define what the partner is responsible for improving. This should include release quality, incident response, integration stability, documentation traceability, and support responsiveness. If success is vague, reporting will become vague too.<\/p>\n<\/li>\n<li>\n<p><strong>Knowledge transfer and controlled handoff<\/strong><br \/>Start with shadowing, paired triage, shared backlog review, and limited-scope ownership. Don&#8217;t hand over critical production paths on day one. Let the partner prove they understand the product and its risk profile first.<\/p>\n<\/li>\n<\/ol>\n<h3>Phase four and the metrics that matter<\/h3>\n<ol start=\"4\">\n<li><strong>Continuous improvement cadence<\/strong><br \/>Set regular reviews for release incidents, security findings, integration failures, support backlog, and evidence completeness. Regular reviews enable a support function to stop being reactive and start becoming a measurable operating system.<\/li>\n<\/ol>\n<p>Useful KPIs are mostly operational, not promotional:<\/p>\n<ul>\n<li>\n<p><strong>Release reliability:<\/strong> Are changes landing without avoidable rollback or downstream disruption?<\/p>\n<\/li>\n<li>\n<p><strong>Incident handling:<\/strong> Are critical issues triaged clearly, escalated quickly, and resolved with documented follow-up?<\/p>\n<\/li>\n<li>\n<p><strong>Integration stability:<\/strong> Are interfaces remaining dependable as partner systems and schemas evolve?<\/p>\n<\/li>\n<li>\n<p><strong>Evidence quality:<\/strong> Can the team retrieve design rationale, validation artifacts, and change history without scrambling?<\/p>\n<\/li>\n<li>\n<p><strong>Support responsiveness:<\/strong> Are questions, defects, and high-risk changes getting owner-assigned quickly?<\/p>\n<\/li>\n<\/ul>\n<p>If AI is in scope, align this process to an <a href=\"https:\/\/www.bridge-global.com\/service-models\/ai-transformation-framework\">AI implementation roadmap<\/a> so the support model covers monitoring and governance, not just delivery.<\/p>\n<p>Teams that need broader product ownership across architecture, QA, support, and evolution usually combine this with <a href=\"https:\/\/www.bridge-global.com\/services\/custom-software-development\">custom software development<\/a> under a single operating cadence. As we explored in our guide to implementation planning, the handoff matters less than the shared control model you establish after it.<\/p>\n<p>The practical goal is simple. The partner shouldn&#8217;t become another team to manage. They should become part of how the product stays safe and shippable.<\/p>\n<h2>Answering Your Key Questions<\/h2>\n<h3>How is medical SaaS engineering support different from normal DevOps?<\/h3>\n<p>Standard DevOps focuses on deployment speed, infrastructure reliability, and developer efficiency. Medical SaaS support adds traceability, validation depth, regulated change control, workflow-aware incident handling, and tighter security governance. In healthcare, a successful deployment can still be a bad release if evidence is incomplete or clinical behavior changes unexpectedly.<\/p>\n<h3>When should a startup invest in specialized support?<\/h3>\n<p>Earlier than typically assumed. If you&#8217;re preparing for pilots, enterprise procurement, external integrations, or AI-enabled workflows, you already need more than generic support. Waiting until after a failed audit, delayed implementation, or production incident usually costs more.<\/p>\n<h3>Is it better to build the team in-house or use a partner?<\/h3>\n<p>It depends on your stage and hiring capacity. In-house teams give you a tighter embedded context. Specialized partners give you faster access to roles that are hard to hire and harder to coordinate. Many teams do best with a hybrid model, keeping product ownership internal while using a partner for regulated delivery operations and specialist support.<\/p>\n<h3>What should I ask in the first partner conversation?<\/h3>\n<p>Ask how they manage evidence, integrations, security incidents, release approvals, and post-launch monitoring. Ask who owns what. Ask what artifacts they produce. Ask how they handle failure. Those answers tell you more than a capabilities deck.<\/p>\n<h3>What is the biggest mistake teams make?<\/h3>\n<p>Treating support like a maintenance function. In medical SaaS, support is part of product engineering. If it isn&#8217;t designed into the product lifecycle, the team will keep reacting to preventable risk.<\/p>\n<hr \/>\n<p>If your team is trying to keep a medical SaaS platform secure, auditable, interoperable, and ready for continuous AI-enabled change, working with a specialized <a href=\"https:\/\/www.bridge-global.com\/\">HealthTech software development partner<\/a> can reduce execution risk. Bridge Global supports healthcare product teams with regulated engineering, AI delivery, integration work, and lifecycle support that fits real operating conditions rather than demo environments.<\/p><!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>Your product probably works in demo conditions. The trouble starts after procurement, security review, pilot rollout, and the first serious integration with a hospital system. That&#8217;s the point where many teams discover they don&#8217;t have a product problem. They have &hellip;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":83,"featured_media":56725,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1015],"tags":[1434,1467,1570,1657,1658],"class_list":["post-56726","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","tag-healthtech-software","tag-healthcare-compliance","tag-product-engineering","tag-medical-saas","tag-saas-support"],"featured_image_src":"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/05\/medical-saas-product-engineering-support-tech-healthcare.jpg","author_info":{"display_name":"Preethi Saro Philip","author_link":"https:\/\/www.bridge-global.com\/blog\/author\/preethi\/"},"_links":{"self":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/56726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/users\/83"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/comments?post=56726"}],"version-history":[{"count":2,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/56726\/revisions"}],"predecessor-version":[{"id":56752,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/56726\/revisions\/56752"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/media\/56725"}],"wp:attachment":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/media?parent=56726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/categories?post=56726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/tags?post=56726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}